CNBC Pro

Buying the right health care ETF as the industry races for a coronavirus cure or vaccine

John Davi, chief investment officer of Astoria Portfolio Advisors
WATCH LIVE
Spencer Platt | Getty Images

Everyone is wondering what needs to happen for life to get back a sense of normalcy amid the coronavirus pandemic.  It's pretty obvious — we need a vaccine and or a treatment.

There will be winners and losers in the race for a COVID-19 vaccine and treatment.  Just remember that investing in single stocks carries significantly more risk when compared to investing in a diversified portfolio of stocks such as an exchange-traded fund.

Here are some ETF options:

More In Pro News and Analysis

CNBC Pro‘Don’t be a hero’: Investment pro reveals how to navigate the market, names the tech stocks she’s buying
CNBC ProWhen the bond market flashes a recession warning, these are the stocks to consider, Trivariate says
CNBC ProDeere, Matterport and more: CNBC's 'Halftime Report' traders answer your stock questions